Fierce Biotech February 23, 2024
Conor Hale

Researchers at the Washington University in St. Louis and Lund University in Sweden have taken a step closer toward developing a blood test that could be used during an annual doctor’s office visit to help catch cases of Alzheimer’s disease.

Making a simple and accurate blood test available to primary care providers would upend traditional diagnostic methods, where invasive spinal tap procedures or brain scans typically only come after a patient has begun demonstrating cognitive decline.

The researchers—some of whom previously worked with the Washington University’s spinout C2N Diagnostics, a former Fierce 15 winner and developer of the PrecivityAD blood tests for Alzheimer’s—say this new assay is capable of performing on par with PET scans and analyses of cerebrospinal...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Patient / Consumer, Physician, Primary care, Provider
California Sets 15% Goal for Primary Care Spending by 2034
Lessons from Forward Health: How direct primary care is the future of health care
5 objectives for achieving high-quality primary care at the state level
Are telehealth visits for pediatric primary care associated with higher rates of health care utilization?
70% of Americans want primary care providers to address mental health

Share This Article